Cargando…
The ongoing trends of patient‐derived xenograft models in oncology
Autores principales: | Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668494/ https://www.ncbi.nlm.nih.gov/pubmed/32954687 http://dx.doi.org/10.1002/cac2.12096 |
Ejemplares similares
-
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts
por: Zhuo, Jianyong, et al.
Publicado: (2021) -
Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation
por: Yang, Xinyu, et al.
Publicado: (2021) -
Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016) -
Cardiac Imaging in Cardio-oncology: An Ongoing Challenging
por: Citro, Rodolfo, et al.
Publicado: (2020) -
ATRA sensitized the response of hepatocellular carcinoma to Sorafenib by downregulation of p21-activated kinase 1
por: Wang, Kai, et al.
Publicado: (2023)